Now more than ever, there is reason to be hopeful as we treat our patients’ cancer. Our ability to use, in novel ways "old medicines" and the ever-expanding frontier of new cancer treatments - equip Virginia Cancer Specialists with the tools we need to fight for and alongside our patients.
Georgetown University Hospital, Medical Oncology and Hematology
University of Pennsylvania
Georgetown University School of Medicine
Dr. Irwin’s commitment to caring for and treating oncology and hematology patients led her to join the Loudoun Office of Virginia Cancer Specialists in 2008. She is a member of the American Society of Clinical Oncology and is a national clinical trials researcher. Dr. Irwin regularly lectures in the community for Life With Cancer, has educated the public on clinical trials for the Leukemia and Lymphoma Society, and has given multiple physician Grand Rounds at INOVA Loudoun Hospital to educate her peers on current oncology and hematology cases and developments.
A recognized expert in the fight against breast cancer, Dr. Irwin is part of the national U.S. Oncology Breast Cancer Research Committee, has been interviewed as a breast cancer specialist on television and in magazines, and is repeatedly called on to speak at charity events for breast cancer awareness and prevention.
Awarded multiple commendations for outstanding patient care, Dr. Irwin has a long-standing commitment to providing the best outcomes for her patients. She completed her Internal Medicine residency at the Hospital of the University of Pennsylvania in 2005, where she was awarded the University of Pennsylvania’s Holmes Award in Patient Oriented Evaluative Research. Dr. Irwin went on to complete her Hematology/Oncology fellowship after returning to Georgetown University Hospital’s Lombardi Cancer Center. Her research and clinical focus during fellowship was in breast cancer and she completed a Bone Marrow Transplant rotation at the National Cancer Institute in Bethesda, Maryland.
Virginia Cancer Specialists Collaborating with Caris Life Sciences to Present New Molecular Findings at the 2018 ASCO Annual MeetingRead More
New clinical data for chemotherapy drug administered in metastatic breast cancer co-presented by Dr. Amy Irwin of Virginia Cancer SpecialistsRead More
Phase II Study of Eribulin Mesylate Administered Biweekly in Patients With Human Epidermal Growth Factor Receptor-2–negative Metastatic Breast CancerRead More